Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-03 Sale |
2025-03-03 6:30 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,035 | $30.45 | $214,219 | 261,886 (Direct) |
View |
2024-03-04 Sale |
2024-03-04 6:12 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
3,934 | $41.86 | $164,664 | 329,851 (Direct) |
View |
2023-03-02 Sale |
2023-03-03 4:30 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
1,370 | $31 | $42,465 | 247,068 (Direct) |
View |
2022-01-12 Sale |
2022-01-14 5:01 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
15,000 | $51.85 | $777,684 | 54,488 (Direct) |
View |
2021-12-03 Sale |
2021-12-03 6:43 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $53.56 | $535,637 | 207,413 (Direct) |
View |
2021-09-03 Sale |
2021-09-03 5:57 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $60.12 | $601,180 | 217,155 (Direct) |
View |
2021-06-03 Sale |
2021-06-04 4:16 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $46.87 | $468,695 | 227,155 (Direct) |
View |
2021-03-11 Sale |
2021-03-15 9:08 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $60.15 | $601,528 | 476,317 (Direct) |
View |
2021-03-08 Sale |
2021-03-08 8:01 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $50.65 | $506,470 | 244,061 (Direct) |
View |
2021-03-03 Sale |
2021-03-05 5:26 pm |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $44.78 | $895,634 | 254,061 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-31 Exercise |
2025-04-01 08:00 am |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
25,000 | $0 | 296,785 (Direct) |
View |
2025-03-31 Exercise |
2025-04-01 08:00 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
25,000 | $2.08 | 296,785 (Direct) |
View |
2025-03-03 Option Award |
2025-03-03 6:30 pm |
N/A 2035-03-02 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
90,000 | $0 | 261,886 (Direct) |
View |
2025-01-10 Exercise |
2025-01-13 07:00 am |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 273,820 (Direct) |
View |
2025-01-10 Exercise |
2025-01-13 07:00 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 273,820 (Direct) |
View |
2024-06-27 Exercise |
2024-06-28 08:30 am |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
25,000 | $0 | 273,453 (Direct) |
View |
2024-06-27 Exercise |
2024-06-28 08:30 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
25,000 | $2.08 | 273,453 (Direct) |
View |
2024-03-01 Option Award |
2024-03-04 6:12 pm |
N/A 2034-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
218,750 | $0 | 329,851 (Direct) |
View |
2023-06-02 Exercise |
2023-06-02 2:17 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 244,934 (Direct) |
View |
2023-06-02 Exercise |
2023-06-02 2:17 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 244,934 (Direct) |
View |
2023-03-01 Option Award |
2023-03-03 4:30 pm |
N/A 2033-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
166,250 | $0 | 247,068 (Direct) |
View |
2022-10-21 Exercise |
2022-10-24 08:00 am |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 221,178 (Direct) |
View |
2022-10-21 Exercise |
2022-10-24 08:00 am |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 221,178 (Direct) |
View |
2022-10-17 Exercise |
2022-10-17 8:12 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 221,178 (Direct) |
View |
2022-10-17 Exercise |
2022-10-17 8:12 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 221,178 (Direct) |
View |
2022-05-03 Exercise |
2022-05-03 7:26 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $0 | 220,713 (Direct) |
View |
2022-05-03 Exercise |
2022-05-03 7:26 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $2.08 | 220,713 (Direct) |
View |
2022-03-01 Option Award |
2022-03-03 4:30 pm |
N/A 2032-02-29 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
93,300 | $0 | 120,814 (Direct) |
View |
2022-01-14 Exercise |
2022-01-14 5:15 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 207,413 (Direct) |
View |
2022-01-14 Exercise |
2022-01-14 5:15 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 207,413 (Direct) |
View |
2022-01-12 Exercise |
2022-01-14 5:01 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
15,000 | $0 | 54,488 (Direct) |
View |
2022-01-12 Exercise |
2022-01-14 5:01 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
15,000 | $2.08 | 54,488 (Direct) |
View |
2021-12-03 Exercise |
2021-12-03 6:43 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 207,413 (Direct) |
View |
2021-12-03 Exercise |
2021-12-03 6:43 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 207,413 (Direct) |
View |
2021-11-23 Exercise |
2021-11-23 4:59 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 217,155 (Direct) |
View |
2021-11-23 Exercise |
2021-11-23 4:59 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 217,155 (Direct) |
View |
2021-09-03 Option Award |
2021-09-03 5:57 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 217,155 (Direct) |
View |
2021-09-03 Exercise |
2021-09-03 5:57 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 217,155 (Direct) |
View |
2021-06-03 Option Award |
2021-06-04 4:16 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 227,155 (Direct) |
View |
2021-06-03 Exercise |
2021-06-04 4:16 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 227,155 (Direct) |
View |
2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $0 | 236,899 (Direct) |
View |
2021-04-13 Exercise |
2021-04-13 6:37 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
7,000 | $2.08 | 236,899 (Direct) |
View |
2021-03-11 Exercise |
2021-03-15 9:08 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 476,317 (Direct) |
View |
2021-03-11 Exercise |
2021-03-15 9:08 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 476,317 (Direct) |
View |
2021-03-08 Exercise |
2021-03-08 8:01 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $0 | 244,061 (Direct) |
View |
2021-03-08 Exercise |
2021-03-08 8:01 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
10,000 | $2.08 | 244,061 (Direct) |
View |
2021-03-03 Exercise |
2021-03-05 5:26 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $0 | 254,061 (Direct) |
View |
2021-03-03 Exercise |
2021-03-05 5:26 pm |
N/A N/A |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
20,000 | $2.08 | 254,061 (Direct) |
View |
2021-03-01 Option Award |
2021-03-03 4:27 pm |
N/A 2031-02-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
140,000 | $0 | 140,000 (Direct) |
View |
2020-08-20 Option Award |
2020-08-21 6:21 pm |
N/A 2030-08-19 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
32,904 | $0 | 32,904 (Direct) |
View |
Ownership |
2020-08-20 8:32 pm |
N/A 2029-08-28 |
Kymera Therapeutics Inc. | KYMR | Jacobs Bruce N. Chief Financial Officer |
0 | $0 | 415,397 (Direct) |
View |